EUVIMEDEUVIMED entdecken
Fallbericht

ATYPICAL FRACTURE FEMUR FOLLOWING LONG TERM PREDNISOLONE AND ALENDRONATE MEDICATION: A CASE REPORT

Reddy, B.N., Abdullah Aqueel M

Matrix Science Pharma · 2018

DOI: 10.26480/msp.02.2018.04.05 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Matrix Science Pharma, 2018. Verfasst von Reddy und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years several reports of atypical fracture (AFF) of the femur occurring in postmenopausal osteoporosis patients, on long term bisphosphonate therapy, are noted in the literature.In comparison only, few cases of these type of fractures occurring in patients, on concomitant glucocorticoid and bisphosphonate medication, are reported.Here, we are reporting one such case belonging to this sub-group.

Zitieren

APA

Reddy, B.N., & M, A. A. (2018). ATYPICAL FRACTURE FEMUR FOLLOWING LONG TERM PREDNISOLONE AND ALENDRONATE MEDICATION: A CASE REPORT. Matrix Science Pharma. https://doi.org/10.26480/msp.02.2018.04.05

Vancouver

Reddy, B.N., M AA. ATYPICAL FRACTURE FEMUR FOLLOWING LONG TERM PREDNISOLONE AND ALENDRONATE MEDICATION: A CASE REPORT. Matrix Science Pharma. 2018. doi:10.26480/msp.02.2018.04.05

BibTeX
@article{Reddy2018,
  author = {Reddy and B.N. and M, Abdullah Aqueel},
  title = {ATYPICAL FRACTURE FEMUR FOLLOWING LONG TERM PREDNISOLONE AND ALENDRONATE MEDICATION: A CASE REPORT},
  journal = {Matrix Science Pharma},
  year = {2018},
  doi = {10.26480/msp.02.2018.04.05}
}
Kostenlos starten →